nodes	percent_of_prediction	percent_of_DWPC	metapath
Mivacurium—Wheezing—Bleomycin—melanoma	0.0184	0.0376	CcSEcCtD
Mivacurium—Injection site reaction—Carmustine—melanoma	0.0164	0.0336	CcSEcCtD
Mivacurium—Phlebitis—Bleomycin—melanoma	0.0159	0.0326	CcSEcCtD
Mivacurium—Phlebitis—Dactinomycin—melanoma	0.0149	0.0304	CcSEcCtD
Mivacurium—Cardiac disorder—Vemurafenib—melanoma	0.0145	0.0298	CcSEcCtD
Mivacurium—Angiopathy—Vemurafenib—melanoma	0.0142	0.0291	CcSEcCtD
Mivacurium—Mediastinal disorder—Vemurafenib—melanoma	0.0141	0.0289	CcSEcCtD
Mivacurium—Phlebitis—Carmustine—melanoma	0.0139	0.0285	CcSEcCtD
Mivacurium—Erythema—Vemurafenib—melanoma	0.0136	0.028	CcSEcCtD
Mivacurium—Bronchospasm—Bleomycin—melanoma	0.0117	0.0239	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.0115	0.0236	CcSEcCtD
Mivacurium—Anaphylactic shock—Vemurafenib—melanoma	0.0111	0.0228	CcSEcCtD
Mivacurium—Skin disorder—Vemurafenib—melanoma	0.0108	0.0222	CcSEcCtD
Mivacurium—Injection site reaction—Docetaxel—melanoma	0.0105	0.0216	CcSEcCtD
Mivacurium—Hypotension—Vemurafenib—melanoma	0.0104	0.0213	CcSEcCtD
Mivacurium—Phlebitis—Docetaxel—melanoma	0.00893	0.0183	CcSEcCtD
Mivacurium—Flushing—Bleomycin—melanoma	0.00881	0.0181	CcSEcCtD
Mivacurium—Erythema—Bleomycin—melanoma	0.00826	0.0169	CcSEcCtD
Mivacurium—Flushing—Dactinomycin—melanoma	0.00822	0.0168	CcSEcCtD
Mivacurium—Erythema—Dactinomycin—melanoma	0.00771	0.0158	CcSEcCtD
Mivacurium—Flushing—Carmustine—melanoma	0.00769	0.0158	CcSEcCtD
Mivacurium—Cardiac disorder—Temozolomide—melanoma	0.00743	0.0152	CcSEcCtD
Mivacurium—Flushing—Temozolomide—melanoma	0.00743	0.0152	CcSEcCtD
Mivacurium—Arrhythmia—Carmustine—melanoma	0.0074	0.0152	CcSEcCtD
Mivacurium—Dizziness—Vemurafenib—melanoma	0.00736	0.0151	CcSEcCtD
Mivacurium—Angiopathy—Temozolomide—melanoma	0.00726	0.0149	CcSEcCtD
Mivacurium—Immune system disorder—Temozolomide—melanoma	0.00723	0.0148	CcSEcCtD
Mivacurium—Mediastinal disorder—Temozolomide—melanoma	0.00722	0.0148	CcSEcCtD
Mivacurium—Erythema—Carmustine—melanoma	0.00721	0.0148	CcSEcCtD
Mivacurium—Rash—Vemurafenib—melanoma	0.00702	0.0144	CcSEcCtD
Mivacurium—Dermatitis—Vemurafenib—melanoma	0.00701	0.0144	CcSEcCtD
Mivacurium—Erythema—Temozolomide—melanoma	0.00697	0.0143	CcSEcCtD
Mivacurium—Anaphylactic shock—Bleomycin—melanoma	0.00674	0.0138	CcSEcCtD
Mivacurium—Bronchospasm—Docetaxel—melanoma	0.00654	0.0134	CcSEcCtD
Mivacurium—Hypotension—Bleomycin—melanoma	0.0063	0.0129	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00589	0.0121	CcSEcCtD
Mivacurium—Tachycardia—Carmustine—melanoma	0.00574	0.0118	CcSEcCtD
Mivacurium—Anaphylactic shock—Temozolomide—melanoma	0.00569	0.0117	CcSEcCtD
Mivacurium—Skin disorder—Temozolomide—melanoma	0.00553	0.0113	CcSEcCtD
Mivacurium—Hypotension—Carmustine—melanoma	0.0055	0.0113	CcSEcCtD
Mivacurium—Urticaria—Bleomycin—melanoma	0.00536	0.011	CcSEcCtD
Mivacurium—Cardiac disorder—Docetaxel—melanoma	0.00494	0.0101	CcSEcCtD
Mivacurium—Flushing—Docetaxel—melanoma	0.00494	0.0101	CcSEcCtD
Mivacurium—Angiopathy—Docetaxel—melanoma	0.00483	0.0099	CcSEcCtD
Mivacurium—Immune system disorder—Docetaxel—melanoma	0.00481	0.00986	CcSEcCtD
Mivacurium—Mediastinal disorder—Docetaxel—melanoma	0.0048	0.00984	CcSEcCtD
Mivacurium—Arrhythmia—Docetaxel—melanoma	0.00476	0.00975	CcSEcCtD
Mivacurium—Erythema—Docetaxel—melanoma	0.00464	0.0095	CcSEcCtD
Mivacurium—Urticaria—Temozolomide—melanoma	0.00452	0.00926	CcSEcCtD
Mivacurium—Muscle spasms—Docetaxel—melanoma	0.00446	0.00914	CcSEcCtD
Mivacurium—Rash—Bleomycin—melanoma	0.00425	0.00872	CcSEcCtD
Mivacurium—Dermatitis—Bleomycin—melanoma	0.00425	0.00871	CcSEcCtD
Mivacurium—Rash—Dactinomycin—melanoma	0.00397	0.00813	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00392	0.00803	CcSEcCtD
Mivacurium—Dizziness—Carmustine—melanoma	0.00389	0.00798	CcSEcCtD
Mivacurium—Anaphylactic shock—Docetaxel—melanoma	0.00378	0.00776	CcSEcCtD
Mivacurium—Dizziness—Temozolomide—melanoma	0.00376	0.00771	CcSEcCtD
Mivacurium—Rash—Carmustine—melanoma	0.00371	0.00761	CcSEcCtD
Mivacurium—Dermatitis—Carmustine—melanoma	0.00371	0.0076	CcSEcCtD
Mivacurium—Tachycardia—Docetaxel—melanoma	0.00369	0.00757	CcSEcCtD
Mivacurium—Skin disorder—Docetaxel—melanoma	0.00367	0.00753	CcSEcCtD
Mivacurium—Rash—Temozolomide—melanoma	0.00359	0.00735	CcSEcCtD
Mivacurium—Dermatitis—Temozolomide—melanoma	0.00358	0.00735	CcSEcCtD
Mivacurium—Hypotension—Docetaxel—melanoma	0.00353	0.00725	CcSEcCtD
Mivacurium—Dizziness—Docetaxel—melanoma	0.0025	0.00513	CcSEcCtD
Mivacurium—Rash—Docetaxel—melanoma	0.00239	0.00489	CcSEcCtD
Mivacurium—Dermatitis—Docetaxel—melanoma	0.00238	0.00489	CcSEcCtD
Mivacurium—CHRM3—GPCR downstream signaling—EDN1—melanoma	0.00021	0.00041	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HDAC6—melanoma	0.00021	0.000409	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—melanoma	0.000209	0.000408	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—EDN1—melanoma	0.000208	0.000406	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—CSF2—melanoma	0.000205	0.0004	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—CSF2—melanoma	0.000203	0.000396	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CXCR2—melanoma	0.000201	0.000392	CbGpPWpGaD
Mivacurium—CHRM3—GPCR ligand binding—CXCL8—melanoma	0.000201	0.000392	CbGpPWpGaD
Mivacurium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—melanoma	0.0002	0.00039	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CXCR2—melanoma	0.000199	0.000388	CbGpPWpGaD
Mivacurium—CHRM2—GPCR ligand binding—CXCL8—melanoma	0.000199	0.000388	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CYP17A1—melanoma	0.000198	0.000386	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—RAC2—melanoma	0.000197	0.000386	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PRKCA—melanoma	0.000197	0.000384	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—RAC2—melanoma	0.000196	0.000382	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PRKCA—melanoma	0.000195	0.00038	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—WNT5A—melanoma	0.000194	0.00038	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—VEGFC—melanoma	0.000194	0.00038	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—WNT5A—melanoma	0.000193	0.000376	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—VEGFC—melanoma	0.000193	0.000376	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000191	0.000373	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—EDN1—melanoma	0.00019	0.000372	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—EDN1—melanoma	0.000189	0.000368	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GNA11—melanoma	0.000187	0.000364	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CSF2—melanoma	0.000186	0.000363	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CSF2—melanoma	0.000184	0.00036	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—CXCL8—melanoma	0.000184	0.000358	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—FASN—melanoma	0.000183	0.000357	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—RAC1—melanoma	0.000182	0.000356	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—RAC1—melanoma	0.00018	0.000352	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—SLC5A5—melanoma	0.00018	0.000351	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PRKCA—melanoma	0.000178	0.000348	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—ABCB1—melanoma	0.000178	0.000348	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PRKCA—melanoma	0.000177	0.000345	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—MAP2K2—melanoma	0.000174	0.000341	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GNAQ—melanoma	0.000174	0.000339	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CD44—melanoma	0.000174	0.000339	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—MAP2K2—melanoma	0.000173	0.000337	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—F2R—melanoma	0.000171	0.000333	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of proteins—CTNNB1—melanoma	0.000169	0.000331	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—F2R—melanoma	0.000169	0.00033	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CYP1B1—melanoma	0.000166	0.000325	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—RAC1—melanoma	0.000165	0.000323	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—EDNRB—melanoma	0.000165	0.000323	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PRKCA—melanoma	0.000164	0.00032	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—RAC1—melanoma	0.000164	0.00032	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—EDNRB—melanoma	0.000164	0.00032	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—ERCC2—melanoma	0.000163	0.000318	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PTK2B—melanoma	0.00016	0.000313	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PTK2B—melanoma	0.000159	0.00031	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GNA11—melanoma	0.000156	0.000305	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GAB2—melanoma	0.000156	0.000305	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—FLT1—melanoma	0.000155	0.000303	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GAB2—melanoma	0.000155	0.000302	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GNA11—melanoma	0.000155	0.000302	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PIK3CG—melanoma	0.000154	0.000301	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—FLT1—melanoma	0.000154	0.0003	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PIK3CG—melanoma	0.000152	0.000298	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CXCR4—melanoma	0.000147	0.000287	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—FOXO4—melanoma	0.000147	0.000287	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HDAC2—melanoma	0.000147	0.000287	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CXCR4—melanoma	0.000145	0.000284	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—FOXO4—melanoma	0.000145	0.000284	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HDAC2—melanoma	0.000145	0.000284	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GNAQ—melanoma	0.000145	0.000283	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GNAQ—melanoma	0.000144	0.000281	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PIK3CG—melanoma	0.00014	0.000273	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PIK3CG—melanoma	0.000138	0.00027	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ABCB1—melanoma	0.000137	0.000268	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SYK—melanoma	0.000136	0.000266	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PIK3CD—melanoma	0.000135	0.000264	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SYK—melanoma	0.000135	0.000264	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.000135	0.000263	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PIK3CD—melanoma	0.000134	0.000262	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NGFR—melanoma	0.000134	0.000261	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AKT3—melanoma	0.000134	0.000261	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ITGAV—melanoma	0.000134	0.000261	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ITGAV—melanoma	0.000133	0.000259	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AKT3—melanoma	0.000133	0.000259	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NGFR—melanoma	0.000133	0.000259	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PIK3CG—melanoma	0.000128	0.000251	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PRKCA—melanoma	0.000126	0.000246	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ERCC2—melanoma	0.000125	0.000244	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SOCS1—melanoma	0.000124	0.000242	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PPARG—melanoma	0.000124	0.000242	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—MAP2K1—melanoma	0.000124	0.000242	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—S100B—melanoma	0.000124	0.000242	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PIK3CD—melanoma	0.000123	0.00024	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SOCS1—melanoma	0.000123	0.00024	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—MAP2K1—melanoma	0.000123	0.000239	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—S100B—melanoma	0.000122	0.000239	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PIK3CD—melanoma	0.000122	0.000238	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ERBB4—melanoma	0.000118	0.000231	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PIK3CB—melanoma	0.000118	0.00023	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CDKN2B—melanoma	0.000117	0.000229	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ERBB4—melanoma	0.000117	0.000229	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PIK3CB—melanoma	0.000117	0.000228	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CDKN2B—melanoma	0.000116	0.000227	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CD86—melanoma	0.000113	0.000221	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—CXCL8—melanoma	0.000113	0.000221	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PIK3CD—melanoma	0.000113	0.00022	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—EDN1—melanoma	0.000113	0.00022	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CD86—melanoma	0.000112	0.000219	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—CXCL8—melanoma	0.000112	0.000219	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—ALB—melanoma	0.000111	0.000218	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—EDN1—melanoma	0.000111	0.000218	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—FGF1—melanoma	0.00011	0.000215	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CSF2—melanoma	0.00011	0.000215	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—FGF1—melanoma	0.000109	0.000213	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CSF2—melanoma	0.000109	0.000213	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—IL2—melanoma	0.000108	0.000212	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—E2F1—melanoma	0.000108	0.00021	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—IL2—melanoma	0.000107	0.000209	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PIK3CB—melanoma	0.000107	0.000209	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—E2F1—melanoma	0.000107	0.000208	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PDGFRA—melanoma	0.000107	0.000208	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PIK3CB—melanoma	0.000106	0.000207	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PDGFRA—melanoma	0.000105	0.000206	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ITGB3—melanoma	0.000105	0.000206	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PRKCA—melanoma	0.000105	0.000206	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ITGB3—melanoma	0.000104	0.000204	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PRKCA—melanoma	0.000104	0.000204	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SPP1—melanoma	0.000103	0.000202	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MAP2K2—melanoma	0.000103	0.000201	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CXCL8—melanoma	0.000103	0.000201	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SPP1—melanoma	0.000102	0.0002	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MAP2K2—melanoma	0.000102	0.000199	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CXCL8—melanoma	0.000102	0.000199	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PIK3CG—melanoma	9.88e-05	0.000193	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PIK3CB—melanoma	9.84e-05	0.000192	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—IL2—melanoma	9.84e-05	0.000192	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TERT—melanoma	9.8e-05	0.000191	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—RAC1—melanoma	9.78e-05	0.000191	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PTGS2—melanoma	9.75e-05	0.00019	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—IL2—melanoma	9.74e-05	0.00019	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TERT—melanoma	9.71e-05	0.00019	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—RAC1—melanoma	9.68e-05	0.000189	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PPARG—melanoma	9.53e-05	0.000186	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HIF1A—melanoma	9.37e-05	0.000183	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HIF1A—melanoma	9.28e-05	0.000181	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—KDR—melanoma	8.97e-05	0.000175	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—KDR—melanoma	8.88e-05	0.000173	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PIK3CD—melanoma	8.68e-05	0.00017	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—FN1—melanoma	8.63e-05	0.000168	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ALB—melanoma	8.57e-05	0.000167	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—FN1—melanoma	8.55e-05	0.000167	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PTEN—melanoma	8.5e-05	0.000166	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NOTCH1—melanoma	8.45e-05	0.000165	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NOTCH1—melanoma	8.36e-05	0.000163	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CD80—melanoma	8.27e-05	0.000162	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APC—melanoma	8.26e-05	0.000161	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PIK3CG—melanoma	8.26e-05	0.000161	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—KIT—melanoma	8.26e-05	0.000161	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—NRAS—melanoma	8.26e-05	0.000161	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CD80—melanoma	8.19e-05	0.00016	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PIK3CG—melanoma	8.18e-05	0.00016	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APC—melanoma	8.18e-05	0.00016	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—KIT—melanoma	8.18e-05	0.00016	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—NRAS—melanoma	8.18e-05	0.00016	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—EGF—melanoma	8.16e-05	0.000159	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—EGF—melanoma	8.08e-05	0.000158	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—MAPK3—melanoma	7.91e-05	0.000154	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—MAPK3—melanoma	7.83e-05	0.000153	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—BRAF—melanoma	7.76e-05	0.000152	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—BRAF—melanoma	7.69e-05	0.00015	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PIK3CB—melanoma	7.57e-05	0.000148	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IGF1—melanoma	7.56e-05	0.000148	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—MAPK1—melanoma	7.53e-05	0.000147	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—EGFR—melanoma	7.52e-05	0.000147	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PTGS2—melanoma	7.5e-05	0.000146	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IGF1—melanoma	7.49e-05	0.000146	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—MAPK1—melanoma	7.45e-05	0.000146	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—EGFR—melanoma	7.45e-05	0.000145	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MAP2K1—melanoma	7.31e-05	0.000143	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PIK3CD—melanoma	7.26e-05	0.000142	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MAP2K1—melanoma	7.24e-05	0.000141	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PIK3CA—melanoma	7.19e-05	0.00014	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PIK3CD—melanoma	7.19e-05	0.00014	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PIK3CA—melanoma	7.12e-05	0.000139	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—KRAS—melanoma	7.11e-05	0.000139	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—KRAS—melanoma	7.04e-05	0.000137	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—FGF2—melanoma	6.95e-05	0.000136	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—FGF2—melanoma	6.88e-05	0.000134	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PTEN—melanoma	6.54e-05	0.000128	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PIK3CA—melanoma	6.53e-05	0.000127	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MDM2—melanoma	6.5e-05	0.000127	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PIK3CA—melanoma	6.47e-05	0.000126	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MDM2—melanoma	6.44e-05	0.000126	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ERBB2—melanoma	6.41e-05	0.000125	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ERBB2—melanoma	6.35e-05	0.000124	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PIK3CB—melanoma	6.33e-05	0.000124	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PIK3CB—melanoma	6.27e-05	0.000122	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CXCL8—melanoma	6.08e-05	0.000119	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—HRAS—melanoma	6.04e-05	0.000118	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CXCL8—melanoma	6.02e-05	0.000118	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PIK3CA—melanoma	6e-05	0.000117	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—HRAS—melanoma	5.98e-05	0.000117	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CDKN1B—melanoma	5.94e-05	0.000116	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CDKN1B—melanoma	5.88e-05	0.000115	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—AKT1—melanoma	5.87e-05	0.000115	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CASP3—melanoma	5.82e-05	0.000114	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—AKT1—melanoma	5.82e-05	0.000114	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IL2—melanoma	5.81e-05	0.000113	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—IL6—melanoma	5.78e-05	0.000113	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CASP3—melanoma	5.76e-05	0.000113	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IL2—melanoma	5.76e-05	0.000112	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—IL6—melanoma	5.73e-05	0.000112	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCND1—melanoma	5.67e-05	0.000111	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CTNNB1—melanoma	5.61e-05	0.00011	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCND1—melanoma	5.61e-05	0.00011	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CTNNB1—melanoma	5.56e-05	0.000108	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MMP9—melanoma	5.5e-05	0.000107	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CDKN1A—melanoma	5.48e-05	0.000107	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PTEN—melanoma	5.47e-05	0.000107	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MMP9—melanoma	5.45e-05	0.000106	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NFKB1—melanoma	5.44e-05	0.000106	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CDKN1A—melanoma	5.43e-05	0.000106	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PTEN—melanoma	5.42e-05	0.000106	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NFKB1—melanoma	5.39e-05	0.000105	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—AKT1—melanoma	5.33e-05	0.000104	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—AKT1—melanoma	5.28e-05	0.000103	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—VEGFA—melanoma	4.94e-05	9.64e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—AKT1—melanoma	4.9e-05	9.57e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—VEGFA—melanoma	4.89e-05	9.55e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—STAT3—melanoma	4.89e-05	9.55e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NRAS—melanoma	4.88e-05	9.53e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—STAT3—melanoma	4.84e-05	9.46e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NRAS—melanoma	4.83e-05	9.43e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MAPK3—melanoma	4.67e-05	9.12e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MAPK3—melanoma	4.63e-05	9.03e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PIK3CA—melanoma	4.61e-05	9.01e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MYC—melanoma	4.54e-05	8.87e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MYC—melanoma	4.5e-05	8.79e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MAPK1—melanoma	4.45e-05	8.68e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—EGFR—melanoma	4.44e-05	8.68e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MAPK1—melanoma	4.4e-05	8.6e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—EGFR—melanoma	4.4e-05	8.59e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—KRAS—melanoma	4.2e-05	8.2e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—KRAS—melanoma	4.16e-05	8.12e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PIK3CA—melanoma	3.86e-05	7.53e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PIK3CA—melanoma	3.82e-05	7.46e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—AKT1—melanoma	3.77e-05	7.36e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TP53—melanoma	3.73e-05	7.29e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TP53—melanoma	3.7e-05	7.22e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HRAS—melanoma	3.57e-05	6.97e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HRAS—melanoma	3.53e-05	6.9e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IL6—melanoma	3.42e-05	6.67e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IL6—melanoma	3.38e-05	6.6e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AKT1—melanoma	3.15e-05	6.15e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AKT1—melanoma	3.12e-05	6.09e-05	CbGpPWpGaD
